文献速递白血病

MYC诱导的人急性髓系白血病需要持续的IL-3/GM-CSF共刺激

MYC-induced human acute myeloid leukemia requires a continuing IL-3/GM-CSF costimulus.
PubMed 文献 · Blood · 2020-01-01

该研究在免疫缺陷小鼠异种移植模型中探讨c-MYC过表达与IL-3、GM-CSF、SCF联合或单独暴露对人急性髓系白血病(AML)实验性生成的影响。结果显示,MYC转导的正常人CD34+血细胞仅在IL-3、GM-CSF和SCF存在时产生类似人AML的快速致死、可连续移植的母细胞群;无细胞因子时MYC+细胞正常分化数月,但二次移植到产细胞因子小鼠后迅速生成AML。研究强调这些细胞因子在激活MYC失调的人造血细胞恶性状态中的关键作用。

要点

  • MYC过表达需IL-3/GM-CSF/SCF共刺激才能在异种移植小鼠中诱发人AML。
  • 无细胞因子时MYC+人造血细胞长期正常分化,但二次移植到产细胞因子小鼠后迅速成瘤。
  • 原始CD34+CD38-细胞和晚期粒-巨噬祖细胞(GMP)均可高效生成不可区分的AML。

核心结论

  • MYC诱导的人AML需要持续的IL-3/GM-CSF共刺激,细胞因子在激活MYC失调的人造血细胞恶性状态中起关键作用。

研究设计与样本

  • 在免疫缺陷小鼠异种移植模型中,将转导MYC慢病毒载体的正常人CD34+血细胞移植到转基因产IL-3、GM-CSF和SCF的小鼠或通过共转导策略暴露于IL-3或GM-CSF的普通小鼠。

主要发现

  • MYC转导的人CD34+细胞在产IL-3、GM-CSF和SCF的小鼠中产生层次组织化、快速致死、可连续移植的母细胞群,表型和转录组类似人AML细胞。
  • 无这些细胞因子时,MYC+人细胞在移植小鼠中产生正常淋巴和髓系后代持续数月,但二次移植到产人细胞因子小鼠后迅速生成AML。
  • 从原始CD34+CD38-细胞和晚期粒-巨噬祖细胞(GMP)均可高效获得不可区分的AML。

临床怎么用

  • 提示在MYC失调的人造血细胞中,IL-3/GM-CSF等细胞因子微环境信号可能是AML发生的必要条件,支持靶向细胞因子微环境的治疗思路。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Hematopoietic clones with leukemogenic mutations arise in healthy people as they age, but progression to acute myeloid leukemia (AML) is rare. Recent evidence suggests that the microenvironment may play an important role in modulating human AML population dynamics. To investigate this concept further, we examined the combined and separate effects of an oncogene (c-MYC) and exposure to interleukin-3 (IL-3), granulocyte-macrophage colony-stimulating factor (GM-CSF), and stem cell factor (SCF) on the experimental genesis of a human AML in xenografted immunodeficient mice. Initial experiments showed that normal human CD34+ blood cells transduced with a lentiviral MYC vector and then transplanted into immunodeficient mice produced a hierarchically organized, rapidly fatal, and serially transplantable blast population, phenotypically and transcriptionally similar to human AML cells, but only in mice producing IL-3, GM-CSF, and SCF transgenically or in regular mice in which the cells were exposed to IL-3 or GM-CSF delivered using a cotransduction strategy. In their absence, the MYC+ human cells produced a normal repertoire of lymphoid and myeloid progeny in transplanted mice for many months, but, on transfer to secondary mice producing the human cytokines, the MYC+ cells rapidly generated AML. Indistinguishable diseases were also obtained efficiently from both primitive (CD34+CD38-) and late granulocyte-macrophage progenitor (GMP) cells. These findings underscore the critical role that these cytokines can play in activating a malignant state in normally differentiating human hematopoietic cells in which MYC expression has been deregulated. They also introduce a robust experimental model of human leukemogenesis to further elucidate key mechanisms involved and test strategies to suppress them.

来源:Blood,查看原文。版权归原作者所有。

引用

  1. Bulaeva E, Pellacani D, Nakamichi N, et al. MYC-induced human acute myeloid leukemia requires a continuing IL-3/GM-CSF costimulus. Blood. 2020. PMID: 33301029. doi:10.1182/blood.2020006374

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。